BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11123870)

  • 1. Prevention of radiation-induced mucositis.
    Johnson JT
    Curr Oncol Rep; 2001 Jan; 3(1):56-8. PubMed ID: 11123870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation treatment breaks and ulcerative mucositis in head and neck cancer.
    Russo G; Haddad R; Posner M; Machtay M
    Oncologist; 2008 Aug; 13(8):886-98. PubMed ID: 18701763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis?
    Mose S; Adamietz IA; Saran F; Thilmann C; Heyd R; Knecht R; Böttcher HD
    Am J Clin Oncol; 1997 Aug; 20(4):407-11. PubMed ID: 9256900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
    Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
    Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-energy He/Ne laser in the prevention of radiation-induced mucositis. A multicenter phase III randomized study in patients with head and neck cancer.
    Bensadoun RJ; Franquin JC; Ciais G; Darcourt V; Schubert MM; Viot M; Dejou J; Tardieu C; Benezery K; Nguyen TD; Laudoyer Y; Dassonville O; Poissonnet G; Vallicioni J; Thyss A; Hamdi M; Chauvel P; Demard F
    Support Care Cancer; 1999 Jul; 7(4):244-52. PubMed ID: 10423050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.
    Antonadou D; Pepelassi M; Synodinou M; Puglisi M; Throuvalas N
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):739-47. PubMed ID: 11849797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study.
    Ertekin MV; Koç M; Karslioglu I; Sezen O
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):167-74. PubMed ID: 14697435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma.
    Kannan V; Bapsy PP; Anantha N; Doval DC; Vaithianathan H; Banumathy G; Reddy KB; Kumaraswamy SV; Shenoy AM
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1005-10. PubMed ID: 9169806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of dose and volume on radiation-induced mucositis.
    Mantini G; Manfrida S; Cellini F; Giammarino D; Petrone A; Vitucci P; Cellini N
    Rays; 2005; 30(2):137-44. PubMed ID: 16294906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study.
    Makkonen TA; Boström P; Vilja P; Joensuu H
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):177-82. PubMed ID: 8083112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma.
    Bourhis J; De Crevoisier R; Abdulkarim B; Deutsch E; Lusinchi A; Luboinski B; Wibault P; Eschwege F
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1105-8. PubMed ID: 10725619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sucralfate in the prevention of radiation-induced oral mucositis.
    Cengiz M; Ozyar E; Oztürk D; Akyol F; Atahan IL; Hayran M
    J Clin Gastroenterol; 1999 Jan; 28(1):40-3. PubMed ID: 9916664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoglobulin for prevention of radiogenic mucositis].
    Mose S; Adamietz IA; Thilmann C; Saran F; Heyd R; Knecht R; Böttcher HD
    HNO; 1995 Jul; 43(7):421-6. PubMed ID: 7672999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Z-100 as radiation mucositis protector in head and neck tumor management].
    Miyashita T; Morita S; Shibuya H; Takeda M; Horiuchi J
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):295-7. PubMed ID: 8177707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy.
    Geara FB; Peters LJ; Ang KK; Garden AS; Tucker SL; Levy LB; Brown BW
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):455-62. PubMed ID: 8655367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy.
    Rastogi M; Khurana R; Revannasiddaiah S; Jaiswal I; Nanda SS; Gupta P; Chufal KS; Bhatt ML
    Support Care Cancer; 2017 May; 25(5):1439-1443. PubMed ID: 27987094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How I treat...oropharyngeal mucositis associated with radiotherapy for head and neck cancer].
    Piret P; Deneufbourg JM
    Rev Med Liege; 2004 Mar; 59(3):120-7. PubMed ID: 15139398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of benzydamine oral rinse in prevention and management of radiation-induced oral mucositis: A double-blind placebo-controlled randomized clinical trial.
    Sheibani KM; Mafi AR; Moghaddam S; Taslimi F; Amiran A; Ameri A
    Asia Pac J Clin Oncol; 2015 Mar; 11(1):22-7. PubMed ID: 25471468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system.
    El-Sayed S; Nabid A; Shelley W; Hay J; Balogh J; Gelinas M; MacKenzie R; Read N; Berthelet E; Lau H; Epstein J; Delvecchio P; Ganguly PK; Wong F; Burns P; Tu D; Pater J
    J Clin Oncol; 2002 Oct; 20(19):3956-63. PubMed ID: 12351592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The problem of radiogenic and chemotherapy-induced mucositis of the mouth and and oropharynx exemplified by accelerated radiochemotherapy with carboplatin in patients with inoperable squamous epithelial carcinomas of the head-/neck area. Heidelberg experiences].
    Dietz A; Nollert J; Maier H; Rudat V; Flentje M
    HNO; 1995 Jul; 43(7):403-13. PubMed ID: 7545657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.